Close

Analyst Ratings for Intra-Cellular Therapies (ITCI)

ITCI Rating Summary

ITCI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ITCI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $81.46 (+24.6%) * Over Last 12-Mos
Rating Score: 8.5 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/3/2024 Baird Joel Beatty New Coverage Outperform
(N/A)
83.00
(N/A)
71.62
(65.37)
-8.73% Details
12/11/2023 TD Cowen Joseph Thome New Coverage Outperform
(N/A)
75.00
(N/A)
60.29
(65.37)
8.43% Details
Like ITCI Ratings? Also take a look at TARS, TEVA, PCVX

ITCI Ratings News